Hypogammaglobulinemia and infections in patients with multiple sclerosis treated with anti-CD20 treatments: a systematic review and meta-analysis of 19,139 multiple sclerosis patients

BackgroundRecent years have seen the emergence of disease-modifying therapies in multiple sclerosis (MS), such as anti-cluster of differentiation 20 (anti-CD20) monoclonal antibodies, aiming to modulate the immune response and effectively manage MS. However, the relationship between anti-CD20 treatm...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Anas Elgenidy, Nagham Nader Abdelhalim, Mohammed Al-mahdi Al-kurdi, Lobna A. Mohamed, Mohamed M. Ghoneim, Ahmed Wagdy Fathy, Hazem Khaled Hassaan, Ahmed Anan, Omar Alomari
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Frontiers Media S.A. 2024-04-01
Saila:	Frontiers in Neurology
Gaiak:	anti-CD20 meta-analysis multiple sclerosis hypogammaglobulinemia infections
Sarrera elektronikoa:	https://www.frontiersin.org/articles/10.3389/fneur.2024.1380654/full
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!